Advertisement

Pharmaceutisch Weekblad

, Volume 14, Issue 4, pp 253–257 | Cite as

Delivery of hormones: some new concepts

  • W. A. J. J. Hermens
Drugs in the Pipeline

Abstract

Some new concepts in the delivery of hormones are described. Transmucosal or transdermal penetration of hormones can be facilitated, often by the use of absorption enhancers. Studies of nasal insulin delivery are described. Recently developed iontophoretic delivery devices can be useful for pulsatile transdermal administration of peptide hormones. A self-regulating delivery system releasing insulin in response to glucose levels is described. A vaginal ring relasing ethinylestradiol and 3-ketodesogestrel is a new concept in long-acting contraception. A nasal estradiol formulation, containing the absorption enhancer dimethyl-β-cyclodextrin, is an interesting alternative to oral and transdermal delivery of female sex hormones.

Keywords

Contraceptive steroids Hormone delivery systems Insulin Oestrogen 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Verhoef JC, Boddé HE, De Boer AG, et al. Transport of peptide and protein drugs across biological membranes. Eur J Drug Metab Pharmacokinet 1990;15:83–93.Google Scholar
  2. 2.
    Hermens WAJJ, Merkus FWHM. The influence of drugs on nasal ciliary movement. Pharm Res 1987;4:445–9.PubMedGoogle Scholar
  3. 3.
    Hermens WAJJ, Hooymans PM, Verhoef J, Merkus FWHM. Effects of absorption enhancers on human nasal tissue ciliary movementin vitro. Pharm Res 1990;7:144–6.PubMedGoogle Scholar
  4. 4.
    Collens WS, Goldzieher MA. Absorption of insulin by nasal mucous membrane. Proc Soc Exp Med 1932;29:756–8.Google Scholar
  5. 5.
    Hirai S, Yashiki T, Mima H. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int J Pharm 1981;9:173–84.Google Scholar
  6. 6.
    Gordon GS, Moses AC, Silver RD, Flier JS, Carey MC. Nasal absorption of insulin: enhancement by hydrophobic bile salts. Proc Natl Acad Sci USA 1985;82: 7419–23.PubMedGoogle Scholar
  7. 7.
    Lee VHL, Dodda Kashi S. Nasal peptide and protein absorption promotors: aminopeptidase inhibition as a predictor of absorption enhancement potency of bile salts. Proc Int Symp Control Rel Bioact Mater 1987;14:55–6.Google Scholar
  8. 8.
    Longenecker JP, Moses AC, Flier JS, Carey MC, Dubovi EJ. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J Pharm Sci 1987;76:351–5.PubMedGoogle Scholar
  9. 9.
    Deurloo MJM, Hermens WAJJ, Romeijn SG, Verhoef J, Merkus FWHM. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats. Pharm Res 1989;6:853–56.PubMedGoogle Scholar
  10. 10.
    Drejer K, Vaag A, Bech K, Hansen PE, Sorense AR, Mygind N. Pharmacokinetics of intranasally administered insulin with phospholipid as absorption enhancer. Diabetologica 1991;33 Suppl:A61.Google Scholar
  11. 11.
    Holman RR and Steemson J. Clinical trial of a new nasal insulin preparation. Diabetes 1991;40 Suppl:424A.Google Scholar
  12. 12.
    Chien YW, Lelawongs P, Siddique 0, Sun Y, Shi WM. Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices. J Contr Rel 1990;13:263–78.Google Scholar
  13. 13.
    Meyer BR, Kreis W, Eschback J, O'Mara V, Rosen S, Sibalis D. Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin Pharmacol Ther 1988;44:607–12.PubMedGoogle Scholar
  14. 14.
    Chien YW, Banga AK. Potential developments in systemic delivery of insulin. Drug Devel Ind Pharm 1989;15:1601–34.Google Scholar
  15. 15.
    Heller J, Chang AC, Rodd G, Grodsky GM. Release of insulin from pH-sensative poly(ortho esters). J Contr Rel 1990;13:295–302.Google Scholar
  16. 16.
    Sam AP. Controlled-release contraceptive devices. In: Hincal AA, Kas S, Sumnu M, eds. Minutes 5th International Pharmaceutical Technology Symposium New approaches to the controlled drug delivery. Paris: Editions de Santé, 1991:271–84.Google Scholar
  17. 17.
    Hermens WAJJ, Belder CWJ, Merkus JMWM, Hooymans PM, Verhoef J, Merkus FWHM. Intranasal estradiol administration to oophorectomized women. Eur J Obstet Gynecol Reprod Biol 1991;40:35–41.PubMedGoogle Scholar
  18. 18.
    Whitehead MI, Fraser D, Schenkel L, Crook D, Stevenson JC. Transdermal administration of oestrogen/progestagen hormone replacement therapy. Lancet 1990;335:310–2.PubMedGoogle Scholar
  19. 19.
    Hermens WAJJ, Belder CWJ, Merkus JMWM, Hooymans PM, Verhoef J, Merkus FWHM. Intranasal administration of estradiol in combination with progesterone to oophorectomized women: a pilot study. Eur J Obstet Gynecol Reprod Biol 1992;43:65–70.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1992

Authors and Affiliations

  • W. A. J. J. Hermens
    • 1
  1. 1.Streekziekenhuis Het Nieuwe SpittaalGZ Zutphenthe Netherlands

Personalised recommendations